Arcellx Inc. (NASDAQ:ACLX) saw a downside of -0.34% to close Friday at $34.78 after subtracting -$0.12 on the day. The 5-day average trading volume is 804,060 shares of the company’s common stock. It has gained $37.63 in the past week and touched a new high 2 times within the past 5 days. An average of 483,505 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 597,554.
ACLX’s 1-month performance is 3.08% or $0.94 on its low of $32.62 reached on 08/14/23. The company’s shares have touched a 52-week low of $15.63 and high of $48.92, with the stock’s rally to the 52-week high happening on 05/11/23. YTD, ACLX has achieved 12.27% or $3.80 and has reached a new high 15 times. However, the current price is down -28.90% from the 52-week high price.
Insider Transactions
ACLX stock investors last saw insider trading activity on Aug 04.Heery Christopher (Chief Medical Officer) most recently sold 3,000 shares at $35.38 per share on Aug 04. This transaction cost the insider $106,133. Chief Medical Officer, Heery Christopher, sold 3,000 shares at a price of $31.75 on Jul 03. Then, on Jun 01, Director Carroll Jill sold 25,556 shares at a price of $44.35 per share. This transaction amounted to $1,133,317.
Valuation Metrics
ACLX stock has a beta of -0.62. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 52.42 while the price-to-book (PB) in the most recent quarter is 5.70, with the price to cash flow ratio at 16.01.
Arcellx Inc.’s quick ratio for the period ended June 29 was 3.60, with the current ratio over the same period at 3.60. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.03, while the total debt to equity was 0.16. The firm’s gross profit as reported stood at $1.72 million against revenue of $191.26 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -29.01% to -$23.85 million, while revenue of -$27.34 million was -14.63% off the previous quarter. Analysts expected ACLX to announce -$0.31 per share in earnings in its latest quarter, but it posted -$0.5, representing a -61.30% surprise. EBITDA for the quarter stood at more than -$31.26 million. ACLX stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 329.86 million, with total debt at $93.64 million. Shareholders hold equity totaling $48.36 million.
Let’s look briefly at Arcellx Inc. (ACLX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 53.45% to suggest the stock is trending Neutral, with historical volatility in this time period at 37.93%.
The stock’s 5-day moving average is $34.97, reflecting a +3.33% or $1.12 change from its current price. ACLX is currently trading +2.72% above its 20-day SMA, +15.93% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -17.15% and SMA200 by+48.13%.
Stochastic %K and %D was 49.23% and 52.49% and the average true range (ATR) pointed at 1.57. The RSI (14) points at 52.24%, while the 14-day stochastic is at 43.11% with the period’s ATR at 1.54. The stock’s 9-day MACD Oscillator is pointing at 0.44 and 0.56 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Arcellx Inc. (NASDAQ: ACLX), Truist launched coverage with a Buy rating. Analysts offering their rating for ACLX stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate ACLX as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 7 have offered a “buy” rating.
What is ACLX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $49.00 and a high of $58.00, with their median price target at $51.50. Looking at these predictions, the average price target given by analysts is for Arcellx Inc. (ACLX) stock is $52.25.
